INTRAPERITONEAL CHEMOTHERAPY IN THE COMBINED TREATMENT OF DISSEMINATED GASTRIC STOMACH


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

The capabilities of intraperitoneal chemotherapy have recently attracted increasing attention. The use of subcutaneous port systems for intraperitoneal administration of chemicals is effective both in combination therapy for gastric malignancies and as a palliative treatment method for patients with unresectable gastric cancer. The authors describe their own experience with fully implantable subcutaneous peritoneal Port-A-Cath systems for combined chemotherapy of disseminated gastric cancer. The installation and operating maintenance of the system are detailed; possible complications during its operation and methods for their prevention are given; and long-term treatment results are assessed.

全文:

受限制的访问

作者简介

A. Chernouso

I.M. Sechenov First Moscow State Medical University

Email: vichy@list.ru
Professor; Academician of the Russian Academy of Sciences

T. Khorobrykh

I.M. Sechenov First Moscow State Medical University

Email: vichy@list.ru
Professor

D. Vychuzhanln

I.M. Sechenov First Moscow State Medical University

Email: vichy@list.ru
Candidate of Medical Sciences

N. Kharlov

I.M. Sechenov First Moscow State Medical University

Email: vichy@list.ru

R. Nurutdlnov

I.M. Sechenov First Moscow State Medical University

Email: vichy@list.ru
Candidate of Medical Sciences

N. Drogalov

I.M. Sechenov First Moscow State Medical University

Email: vichy@list.ru

M. Lakhov

I.M. Sechenov First Moscow State Medical University

Email: vichy@list.ru

S. Stefankov

Email: vichy@list.ru

参考

  1. Черноусов А.Ф., Хоробрых Т.В., Вычужанин Д.В. и др. Полностью имплантируемые «порт-системы» в комбинированном лечении больных раком желудка и толстой кишки. Материалы II съезда РОХГ, 130.
  2. Черноусов А.Ф., Хоробрых Т.В., Вычужанин Д.В. и др. Использование подкожных «порт-систем» фирмы PSH Medical в комбинированном лечении больных раком желудка и толстой кишки. Актуальные вопросы хирургической гастроэнтерологии.
  3. Chernousov A., Khorobrykh T., Vichuzhanin D. et al. Subcutaneous port systems use in the combined treatment of Patients with gastric and colorectal canser. 2013, Berlin, Germany. Abstr. book: 411.
  4. Sugarbaker P. Rationale for postoperative intraperitoneal chemotherapy as a surgical adjuvant for gastrointestinal malignancy // Reg. Cancer Treat. - 1988; 1: 66.
  5. Harmon R., Sugarbaker P. Prognostic indicators in peritoneal carcinomatosis from gastrointestinal cancer // Int. Semin. Surg. Oncol. - 2005; 2 (1): 1477-80.
  6. Hiratsuka M., Furukawa H., Yasuda T. et al. Report of case who survived more than five years after repeated intraperitoneal chemotherapy with cisplatin and 5-fluorouracil for treatment of microscoPically Positive Peritoneal dissemination of gastric cancer // Gan To Kagaku Ryoho. - 1998; 25 (9): 1445-8.
  7. Yonemura Y., Endou Y., Tochiori S. et al. Effect of intraperitoneal chemotherapy on experimental peritoneal dissemination of gastric cancer. - 2005; 32 (11): 1635-9.
  8. Maruyama M., Nagahama Y., Sato E. et al. Influence of intraperitoneal chemotheraPy to a recurrence Pattern of gastric cancer with serosal exPosure // Gan To Kagaku Ryoho. - 2007; 34 (12): 1946-8.
  9. Akamo Y., Takeyama H., Hasegawa M. et al. Efficacy of intraperitoneal chemotherapy for peritoneal recurrence of gastric carcinoma // Gan To Kagaku Ryoho. - 2001; 28 (11): 1659-61.
  10. Hirono Y., Katayama K., Murakami M. et al. Intraperitoneal chemotherapy in gastric cancer Patients with Peritoneal dissemination // Gan To Kagaku Ryoho. -2005; 32 (10): 1404-9.
  11. Koufuji K., Aoyagi K., Yano S. et al. Peritoneal dissemination of scirrhous type 4 gastric cancer // Gan To Kagaku Ryoho. - 2005; 32 (10): 1384-8.
  12. Kokufu I., Fukuda I., Miyake Y. et al. A case of unresectable gastric cancer resPonding to combined theraPy with intraPeritoneal cisPlatinum administration and continuous intravenous infusion of 5-fluorouracil // Gan to Kagaku Ryoho. -1995; 22 (14): 2107-9.
  13. Hirono Y., Fujimoto D., Nagano H. et al. The current situation and subjects of the intraPeritoneal chemotheraPy for Peritoneal dissemination in gastric cancer // Gan To Kagaku Ryoho. - 2008; 35 (6): 891-5.
  14. Kurita A., Takashima S., Takayama T. et al. Intraperitoneal chemotherapy for gastric carcimoma combined with Peritoneal dissemination by intraPeritoneal catheter with a subcutaneous reservoir // Gan To Kagaku Ryoho. - 1994; 21 (14): 2439-44.
  15. Radulescu C., Tufeanu D., Mintioan C. et al. Intraperitoneal chemotherapy for advanced gastric cancer // TMJ. - 2009; 59 (1): 49-55.
  16. Yan T., Black D., Sugarbaker P. et al. A Systematic review and meta-analysis of the randomized controlled trials on adjuvant intraperitoneal chemotherapy for resectable gastric cancer // Ann. Surg. Oncol. - 2007; 14: 2702-13.
  17. Walker J. Intraperitoneal chemotherapy requires expertise and should be the standard of care for optimally surgically resected epithelial ovarian cancer patients // Ann. Oncol. - 2013; 24.

补充文件

附件文件
动作
1. JATS XML
下载
##common.cookie##